Gao et al. demonstrated increased expression of HSP70 in residual cancer cells post-RFA treatment as well as HSP70 promotion of pancreatic cancer growth via the activation of AKT-mTOR signalling [41]. The gene discussed is MTOR; the disease is cancer.